AdaptHealth (NASDAQ: AHCO) insider transactions
In the twelve months to 10 November 2026, executives and directors of AdaptHealth reported 3 open-market sales of 27,550 shares ($278,288) and 10 open-market purchases of 2,571,018 shares ($24.9m), by 6 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 9 September 2026 | Currie Harriss T | Chief Financial Officer | Grant or award | +141,372 | — | 141,372 | Form 4 |
| 7 August 2026 | Wolf Dale B | Director | Open-market purchase | +20,000 | $5.86 | 34,000 | Form 4 |
| 6 August 2026 | Wolf Dale B | Director | Open-market purchase | +20,000 | $6.37 | 143,234 | Form 4 |
| 6 August 2026 | Samet Kenneth A | Director | Open-market purchase | +23,500 | $6.38 | 48,569 | Form 4 |
| 1 July 2026 | Schuster III Russell E. | Chief Commercial Officer | Open-market sale, 10b5-1 plan | −11,275 | $10.44 | 125,263 | Form 4 |
| 24 June 2026 | Samet Kenneth A | Director | Grant or award | +18,999 | — | 18,999 | Form 4 |
| 24 June 2026 | Samet Kenneth A | Director | Grant or award | +6,070 | $9.89 | 25,069 | Form 4 |
| 24 June 2026 | Wolf Dale B | Director | Grant or award | +18,999 | — | 123,234 | Form 4 |
| 24 June 2026 | Lundberg Theodore B. | Director | Grant or award | +18,999 | — | 892,495 | Form 4 |
| 24 June 2026 | Coppens Bradley J | Director | Grant or award | +18,999 | — | 96,345 | Form 4 |
| 24 June 2026 | Belinfanti Gregory | Director | Grant or award | +18,999 | — | 104,269 | Form 4 |
| 24 June 2026 | Connors Terence J | Director | Grant or award | +18,999 | — | 95,262 | Form 4 |
| 24 June 2026 | Weaver Susan T | Director | Grant or award | +18,999 | — | 40,345 | Form 4 |
| 24 June 2026 | Williams David Solomon III | Director | Grant or award | +18,999 | — | 64,044 | Form 4 |
| 1 June 2026 | Schuster III Russell E. | Chief Commercial Officer | Open-market sale, 10b5-1 plan | −11,275 | $10.06 | 136,538 | Form 4 |
| 27 May 2026 | McFadden Daniel Edward | Chief Operating Officer | Grant or award | +20,134 | — | 103,376 | Form 4 |
| 20 March 2026 | Cashin Richard M JR | — | Open-market purchase | +447,100 | $9.91 | 16,312,698 | Form 4 |
| 19 March 2026 | Cashin Richard M JR | — | Open-market purchase | +727 | $9.94 | 15,865,598 | Form 4 |
| 13 March 2026 | Prast Albert A. | Chief Technology Officer | Option exercise | +89,451 | $4.38 | 532,358 | Form 4 |
| 13 March 2026 | Prast Albert A. | Chief Technology Officer | Shares withheld for tax | −58,203 | $10.33 | 474,155 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the AdaptHealth page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.